Kaytec D Tablet is a combination pharmaceutical formulation containing Domperidone and Ranitidine, designed to manage gastrointestinal disorders effectively. Domperidone, a peripheral dopamine antagonist, enhances gastrointestinal motility by increasing the movement of the stomach and intestines, thereby facilitating gastric emptying and reducing symptoms such as nausea and vomiting. Ranitidine, a histamine H2 receptor antagonist, decreases gastric acid secretion by blocking H2 receptors on gastric parietal cells, providing relief from acid-related conditions such as gastroesophageal reflux disease (GERD), peptic ulcers, and Zollinger-Ellison syndrome. The synergistic action of these active ingredients makes Kaytec D Tablet particularly useful in treating dyspepsia, acid reflux, and other upper gastrointestinal tract disturbances where both acid suppression and improved motility are required. The medication should be administered as per the prescribing physician’s guidance, considering patient-specific factors including medical history and concomitant medications. Common side effects may include headache, dry mouth, or gastrointestinal discomfort, and caution is advised in patients with cardiac arrhythmias or hepatic impairment. Kaytec D Tablet is contraindicated in individuals with hypersensitivity to either component or in those with gastrointestinal bleeding or obstruction. Regular monitoring and adherence to recommended dosages are essential to ensure therapeutic efficacy and minimize adverse effects.